Related Experiment Video

Updated: Aug 9, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
12:37

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

Different effects of propranolol, phenylephrine, and saline volume loading on catecholamine-induced left ventricular

Ichiro Ohba1, Yutaka Otsuji, Kensaburo Shiki

  • 1First Department of Internal Medicine, Kagoshima University School of Medicine, Japan.

International Heart Journal
|April 12, 2006
PubMed

Insights

Propranolol, phenylephrine, and saline effectively reversed dobutamine-induced left ventricular outflow tract (LVOT) obstruction in a canine model of acute coronary syndrome (ACS). Each treatment offered distinct hemodynamic benefits, suggesting varied clinical applications for managing LVOT obstruction during ACS.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hemodynamics

Background:

  • Catecholamine infusion can precipitate left ventricular outflow tract (LVOT) obstruction in acute coronary syndrome (ACS) patients, leading to hemodynamic deterioration.
  • Understanding effective reversal strategies for dobutamine-induced LVOT obstruction is critical for patient management during ACS.

Purpose of the Study:

  • To compare the efficacy of propranolol, phenylephrine infusion, and rapid saline loading in reversing dobutamine-induced LVOT obstruction.
  • To assess the distinct hemodynamic effects of each intervention in a canine model of ACS.

Main Methods:

  • Acute coronary syndrome (ACS) was induced in 21 open-chest dogs via left anterior descending artery ligation.
  • Left ventricular outflow tract (LVOT) obstruction (gradient > 30 mmHg) was induced using dobutamine infusion.
  • Hemodynamic effects of propranolol infusion (n=8), phenylephrine infusion (n=7), and saline loading (n=6) were evaluated.

Main Results:

  • All interventions significantly improved the LVOT pressure gradient, with no significant difference between treatments.
  • Phenylephrine markedly increased aortic pressure, while saline loading significantly boosted cardiac output.
  • Propranolol was unique in significantly decreasing diastolic pulmonary artery pressure.

Conclusions:

  • Propranolol, phenylephrine, and saline loading are similarly effective in reversing dobutamine-induced LVOT obstruction in a canine ACS model.
  • Each intervention exhibits unique hemodynamic profiles, indicating potentially different clinical indications for managing LVOT obstruction.
  • Further research is warranted to elucidate optimal therapeutic strategies based on individual patient hemodynamic status.

More Related Videos

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...